Rugiet Health Review: The Formulation Is Genuinely Different — And There's a Third Ingredient Most Buyers Won't Recognise

What Is Rugiet Health?

Rugiet Health operates from 310 Comal St, Austin, Texas, and the BBB records it as having started trading on 5 March 2020. It is BBB accredited with an A+ rating, accredited as of 26 November 2025, and holds roughly 4.3 stars on Trustpilot across about 1,200 reviews. On the headline credentials it does well.

The product line runs across six areas: Ready (the 3-in-1 ED troche), Boost (a daily tadalafil-plus-DHEA chewable), Grower (tadalafil plus minoxidil for ED and hair together), injectable TRT, Recharge for sleep, and Weigh-In for weight. There is also a longevity line covering NAD+ and sermorelin.

What genuinely distinguishes Rugiet is the delivery format and the third ingredient. Ready is a sublingual troche that dissolves under the tongue rather than a tablet you swallow, which Rugiet says produces onset in about 15 minutes with effects lasting up to 36 hours. And rather than the usual single PDE5 inhibitor, it combines sildenafil, tadalafil and apomorphine — the last of which acts on arousal pathways in the brain rather than on blood flow. Almost nothing else in this market is formulated that way.

Rugiet handles the regulatory language correctly. Every compounded product carries the statement that it 'is a compounded drug product and requires a prescription. Compounded drugs are not approved by FDA and do not undergo review or verification by FDA for safety, effectiveness, or quality.' Its side-effect lists are reasonably complete, and it publishes an important cross-product warning most competitors would omit: do not take Grower within 24 hours of Ready, Boost or Go Long, because they all contain tadalafil.

Where it falls down is commercial. There is no price on any product page, on the homepage, or on the landing pages — you complete a health questionnaire first and see cost afterwards. And its BBB file, despite the A+, contains 38 complaints in three years dominated by a single theme: recurring charges customers say they never knowingly agreed to.

The Product Range & What It Costs

The blank column is the finding. On 7 August 2026 we could not locate a price for Ready, Boost, Grower, Recharge or Weigh-In anywhere on rugiet.com — not on the product pages, not on the dedicated landing pages, not on the homepage. Every route ends at a health questionnaire, with pricing shown afterwards. The only figures Rugiet publishes are for TRT: plans from $139 a month plus $49 for blood testing. The $149–$269 monthly range for Ready comes from independent reviewers who went through the funnel, and we present it as their reporting rather than as verified from Rugiet. Requiring a medical intake before prescribing is entirely proper; requiring it before quoting a price is a sales decision, and it means you cannot compare Rugiet against alternatives without handing over your health history first.

What's In These Products — Including the Ingredient Worth Reading About

All the ED products, and the hair and sleep products, are compounded. Rugiet says so clearly on each page in the correct terms: compounded drugs 'are not approved by FDA and do not undergo review or verification by FDA for safety, effectiveness, or quality.' That is the right disclosure and it is not buried.

The ingredient that needs unpacking is apomorphine, because most buyers will not have encountered it and Rugiet describes it only as something that 'activates arousal pathways in the brain'. That is accurate as far as it goes. Apomorphine is a dopamine agonist. Despite the name it is not an opioid and is unrelated to morphine.

There is no FDA-approved apomorphine product for erectile dysfunction in the United States. The apomorphine products FDA has approved — Apokyn injection, Onapgo, and the Kynmobi sublingual film — are indicated for 'off' episodes in Parkinson's disease. A sublingual apomorphine tablet for ED, marketed as Uprima in some countries, was never approved in the US.

The interaction worth knowing about is specific and serious. FDA labelling for apomorphine states that, based on reports of profound hypotension and loss of consciousness when apomorphine was given with ondansetron, concomitant use with 5-HT3 antagonists — including ondansetron, granisetron, dolasetron and palonosetron, and also alosetron — is contraindicated. Ondansetron is an extremely common prescription for nausea, and readers of this site should note that it is frequently prescribed to manage GLP-1 nausea. If you take a GLP-1 and have ondansetron on hand, raise this with the prescriber before starting Ready.

A fair caveat: the apomorphine dose in a compounded ED troche is far lower than Parkinson's dosing, and the contraindication above derives from approved products at their doses. But the compounded product's dose, absorption and interaction profile have not been reviewed by the FDA — that is what 'not FDA-approved' means — so the prudent course is to assume the labelled interactions apply and tell your prescriber and your pharmacist everything you take.

Apomorphine's other labelled effects are worth anticipating too: nausea and vomiting are common, and it can cause orthostatic hypotension and somnolence, including sudden onset of sleep. Layer that onto a product that also contains two PDE5 inhibitors, both of which lower blood pressure, and Ready contains three agents that can drop your blood pressure at once. Rugiet's own side-effect list does mention dizziness, drowsiness and nausea. Stand up slowly the first time, and do not plan to drive.

One more thing, and this one is to Rugiet's credit: it publishes a warning that most multi-product sellers would leave out, telling customers not to take Grower within 24 hours of Ready, Boost or Go Long because they all contain tadalafil. If you subscribe to more than one Rugiet product, that warning is the most important sentence on the site.

The Consultation Process

Eligibility

• •Adults in the United States, by prescription only after clinician review. Availability varies by product and state.
• •Injectable TRT is currently unavailable in Alabama, Arkansas, Connecticut, Delaware, Georgia, Hawaii, Louisiana, Minnesota, Missouri, North Carolina, North Dakota, Oklahoma, Pennsylvania, Rhode Island and South Carolina — fifteen states, which is a lot, so check before you start the intake.
• •PDE5 inhibitors must never be combined with nitrates in any form. Rugiet publishes the warning that its products 'may also cause a significant drop in blood pressure, especially if taken with nitrates, certain blood pressure medications, alpha blockers, or large amounts of alcohol.' Take that literally.
• •Because Ready contains two PDE5 inhibitors plus apomorphine, the blood-pressure-lowering effects add. Anyone on antihypertensives, alpha-blockers or nitrates, and anyone whose clinician has advised against sexual activity on cardiovascular grounds, should not take it without a specific conversation.
• •FDA labelling contraindicates apomorphine with 5-HT3 antagonists including ondansetron, granisetron, dolasetron and palonosetron, and with alosetron, following reports of profound hypotension and loss of consciousness with ondansetron. Tell your prescriber if you have any of these — ondansetron in particular is commonly prescribed for nausea, including GLP-1 nausea.
• •Rugiet publishes the correct emergency guidance: seek immediate care for an erection lasting more than four hours, sudden loss of vision in one or both eyes, or sudden decrease or loss of hearing. For Grower it adds chest pain, shortness of breath, fainting, sudden dizziness, or signs of fluid buildup such as rapid weight gain or significant swelling.
• •Do not take Grower within 24 hours of Ready, Boost or Go Long — all contain tadalafil, and doubling up risks an overdose of it.
• •Minoxidil, in Grower, can cause fluid retention, swelling and increased heart rate. Anyone with heart disease should discuss it specifically.
• •TRT is not recommended for people with uncontrolled hypertension or certain cardiovascular conditions. Rugiet publishes the relevant risks: injection site reactions, raised red blood cell count, elevated blood pressure, headache, and more seriously blood clots and cardiovascular events. Testosterone also suppresses sperm production — discuss this if fertility matters to you.
• •DHEA, in Boost, is a hormone precursor. It can cause acne, hair loss and mood changes, and is banned by most competitive sporting bodies — relevant if you are drug-tested.

Clinicians, Labs & Pharmacy

Shipping & Support Services

Discreet packaging, with Boost advertised as delivered within 48 hours. Shipping costs are not published — which follows from the fact that no prices are.

• •Sublingual troche format with onset reported at around 15 minutes
• •A genuinely distinctive 3-in-1 formulation rather than a repackaged generic
• •BBB accredited with an A+ rating
• •Roughly 4.3 on Trustpilot across about 1,200 reviews
• •Correct, unburied compounded-drug disclaimers on every product
• •Publishes the cross-product tadalafil warning most sellers would omit
• •Live video consultation and lab monitoring for TRT, as a controlled substance warrants
• •Clear emergency guidance on priapism, vision and hearing loss
• •Answered 31 of 38 BBB complaints and generally offered refunds
• •Phone and email support both published

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who Rugiet Health May Be Best For

• •Men who have tried generic sildenafil or tadalafil tablets and want faster onset or a different mechanism
• •Anyone who prefers a dissolvable format to swallowing a tablet
• •Men wanting TRT handled properly, with a real video consultation and included lab monitoring
• •Buyers who will diarise the renewal date and cancel deliberately rather than drifting

Limitations

• •Start with the ingredient, because it is the thing a buyer is least equipped to evaluate. Apomorphine is not a variation on Viagra — it is a dopamine agonist whose FDA-approved forms treat Parkinson's disease, and there is no FDA-approved apomorphine product for ED in the US. Its labelling carries a contraindication against concomitant use with 5-HT3 antagonists, including ondansetron, following reports of profound hypotension and loss of consciousness. Ondansetron is one of the most commonly prescribed anti-nausea drugs in America, and for this site's readers it is worth stressing that it is frequently given for GLP-1 nausea. The compounded dose here is much lower than Parkinson's dosing, and none of this makes Ready unsafe when properly prescribed — but it does mean the intake questionnaire needs your complete medication list, and that describing apomorphine only as something that 'activates arousal pathways in the brain' undersells what a patient should know.
• •The pricing opacity is the most straightforward criticism. We checked the homepage, all four ED landing pages, the TRT page and the promotional funnel on 7 August 2026 and found no price for Ready, Boost, Grower, Recharge or Weigh-In. Only TRT publishes a figure. Everything else routes to a questionnaire. There is no clinical reason a price cannot be shown before an intake — plenty of competitors manage it — and the effect is that you cannot comparison-shop without first handing over your health history. Independent reviewers who completed the funnel report roughly $149 to $269 a month, which is considerably more than generic tadalafil tablets cost.
• •Then the complaint pattern, which is where the A+ rating and the customer experience diverge. Thirty-eight complaints in three years is a lot, and they cluster tightly: charges for shipments after cancellation, enrolment in recurring plans customers say they never knowingly agreed to, and a cancellation flow described as 'deliberately... confusing as possible'. One complainant reported a $229 charge for an order they say they never placed, leaving their account overdrawn. Rugiet answered 31 of them and generally offered refunds, which is genuinely better than several competitors in this series manage, and is presumably why the accreditation stands. But its stated defence — that the Terms & Conditions and reminder emails constitute adequate disclosure — is a legalistic answer to a design problem. When this many customers report not understanding they had subscribed, the checkout is the thing to fix.
• •Two smaller flags. The Grower page claims '80% see improved hair growth' without citing a source, population or timeframe, which is exactly the kind of headline statistic that should carry a reference. And the promotional funnel runs a countdown timer showing an offer expiring in eight hours on a page that displays no price at all — urgency without information is a combination worth recognising for what it is.
• •None of which means the product does not work. Trustpilot's roughly 4.3 across about 1,200 reviews is a real signal, the sublingual format is a legitimate engineering answer to slow onset, and the TRT programme — live video consultation, included lab monitoring, published state restrictions — is handled more responsibly than most. Rugiet's problem is not its medicine. It is everything surrounding the purchase.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

Rugiet has built something genuinely different. A sublingual troche that dissolves under the tongue, combining two PDE5 inhibitors with apomorphine to work on arousal as well as blood flow, with reported onset around 15 minutes, is not a repackaged generic — it is a real formulation choice. Roughly 4.3 on Trustpilot across about 1,200 reviews suggests it works for a lot of people, and the A+ BBB accreditation and properly handled TRT programme — live video consultation, included lab monitoring, published state restrictions — show a company doing several things right.

The apomorphine deserves more explanation than Rugiet gives it. Buyers should know it is a dopamine agonist whose FDA-approved forms treat Parkinson's disease, that no FDA-approved apomorphine product for ED exists in the US, and that its labelling contraindicates use with ondansetron and other 5-HT3 antagonists after reports of profound hypotension and loss of consciousness. For readers here that last point is not academic: ondansetron is commonly prescribed for GLP-1 nausea. The compounded dose is lower than Parkinson's dosing and this is not a reason to avoid the product — it is a reason to give the intake questionnaire your complete medication list and to raise it directly with the prescriber.

The commercial side is harder to defend. No price appears anywhere on the site for five of its six products; you complete a health questionnaire first and find out afterwards. And 38 BBB complaints in three years cluster on one thing — recurring charges customers say they never knowingly authorised, on a cancellation flow one described as 'deliberately... confusing as possible'. Rugiet answers those complaints and generally refunds, which is more than several competitors do and is presumably why the accreditation survives. But answering complaints about a confusing checkout is not the same as fixing the checkout.

We rate Rugiet Health 3.6 out of 5 — a legitimately innovative product and a properly run TRT service, marked down for hiding its prices and for a subscription experience that generates the same complaint over and over.

Buy it if standard tablets have not worked for you and the format or the third ingredient is worth paying a premium for — but go in knowing you will not see a price until you have completed a medical questionnaire, and treat the renewal date as something to diarise rather than trust. If you simply want ED medication cheaply, generic sildenafil or tadalafil from a provider that publishes its prices will cost you considerably less.

This review is informational only and is not medical advice. Ready, Boost and Grower are compounded products and are not FDA-approved. Never combine PDE5 inhibitors with nitrates. Tell a licensed clinician every medication you take — including ondansetron — before starting, changing or stopping any treatment.